Display Settings:

Format

Send to:

Choose Destination
    Cancer Cell. 2008 Apr;13(4):289-91.

    C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals.

    Source

    Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01605, USA. lucio.castilla@umassmed.edu

    Abstract

    Leukemia-initiating cells can originate from hematopoietic progenitor cells that have acquired self-renewal capacity upon transformation with leukemic fusion genes. In this issue of Cancer Cell, Kirstetter and colleagues describe a mouse model for the frequent CEBPA mutations in human acute myeloid leukemia that result in the synthesis of only the 30kDa isoform, but not the 42kDa isoform of C/EBPalpha. This mutation uncouples C/EBPalpha's roles in myeloid differentiation and proliferation control. Furthermore, this mutation activates self-renewal in committed myeloid progenitor cells and induces myeloid malignancy with complete penetrance that is sustained by leukemia-initiating cells with a committed myeloid molecular signature.

    PMID:
    18394549
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk